Chief Executive Officer
Andre is an experienced healthcare executive with a proven track record in creating strategic partnerships, scaling startups, large enterprise sales agreements, business development and product innovation. Andre is an integral part of the digital solution landscape and is also an active member in the global digital health ecosystem. He has previously held leadership positions at both 2nd.MD and DoseMe.
Chief Technology Officer
Jingqi Wang serves as the Chief Technology Officer at Melax Tech, leading the NLP development team. He has ten years of working experience as a software developer before he joined Melax. In the past years, he primarily worked on the development and improvement of clinical Natural Language Processing (NLP) algorithms and applications. He has contributed to multiple top-ranked systems in biomedical NLP competitions.
Jingcheng Du, PhD
Director of NLP Research
Jingcheng Du, PhD, as the Director of Natural Language Processing at Melax Tech. Additionally, Dr. Du serves as an Adjunct Assistant Professor at University of Texas Health School of Biomedical Informatics. Dr. Du earned his Ph.D. in Medical Informatics from UTHealth, with research focusing on developing AI algorithms such as machine learning, deep learning, natural language processing, and knowledge graph for healthcare applications. Dr. Du has published over 50 peer-reviewed papers, with first-authored papers accepted in leading medical and informatics journals, such as the Lancet HIV, JAMA Network Open, npj digital medicine, and JAMIA. When not working Dr. Du enjoys spending time with his lovely son and playing basketball with his friends.
Frank Manion, PhD
VP for Innovation
Dr. Manion, VP for Innovation, has held executive positions in biomedical informatics support at two major NCI-designated comprehensive cancer centers. He served as Chief Technology Officer and Deputy CIO at the Fox Chase Cancer Center. Until joining Melax he was the Chief Informatics Officer at the Rogel Cancer Center of the University of Michigan. His research interest are the formal semantic representation of biomedical research and clinical data.
Hao Ding, PhD
Director of Operations
A biophysicist by training, Dr. Ding was fascinated by natural language processing, machine learning, and the impact of new technology that will bring to the healthcare industry. Since joining Melax Tech in 2018, Hao has been passionate about expanding business development and revenue generation, managing company daily operation, and ultimately contributing to the improvement of the healthcare system. When not working hard in front of his computer, Hao enjoys spending time with his family and sweating in the gym.
Project Manager and Security Officer
Cynthia Freeney is Melax Tech’s Project Manage and Security Officer. A naturally curious individual, Cynthia has varied experience in the software development space and has held many roles. These include software engineer, consulting engineer, software development manager, scrum master, product owner and software project manager. Since joining Melax Tech in June 2021, Cynthia’s main focus has been establishing and augmenting business, enabling lightweight project and software development processes that promote transparency, predictability and quality. When not actively contributing to the attainment of Melax Tech business goals and objectives, Cynthia enjoys researching information about cybersecurity and serves as the computer and cybersecurity ‘officer’ for family and friends.
Long He is a Full Stack Software Development Engineer at Melax Tech. Long is fascinated by cloud-based system and application architecture design and development, data engineering, NLP, Machine Learning and Blockchain. Prior to joining Melax Tech, Long spent four years working in System Testing and Project Management. At Melax Tech, Long primarily works on NLP applications development, algorithm development, data engineering, and CICD development. He also manages all the official websites of Melax Tech. He enjoys cooking, and working out in his free time.
Maksim Egorov is a software engineer who develops core Natural Language Processing (NLP) products for Melax Tech. Maksim believes that NLP solutions can help physicians make more informed clinical decisions regarding patients. In addition to software development, he incorporates state-of-the-art NLP models to drive excellence in client solutions. Maksim holds a BA in Applied Mathematics from Kazan Federal University and an MS in Computer Science from the University of Houston. In his free time, he enjoys playing ice hockey and practising jiu jitsu.
Bin Lin is Senior Software Engineer at Melax Tech. He has over 15 years’ experience working in Fortune 500 companies. Over the past few years, he has been committed to Machine Learning, especially in the NLP sector. He is recognized as a responsible player and insightful thinker by his teams and clients. Apart from work, there are two things that can give him a considerable sense of achievement: fishing and badminton.
Huy Anh Pham
Huy Anh Pham is a data scientist eager to explore the advancement of Natural Language Processing. Skilled in various programming languages and data mining techniques, Huy Anh has been using his expertise to discover information hidden behind large scaled data for the purpose of saving time and effort. During his time at Melax, he has been collaborating closely in various projects within the biomedical domain, and assisting teams in complex data engineering processes. When not submerged in his work, Huy Anh enjoys sunshine and a peaceful stroll around the park.
Hua Xu, PhD
Dr. Xu is the Founder of Melax Tech. He received his PhD in Biomedical Informatics from Columbia University, and currently is also a part-time professor at The University of Texas Health Science Center at Houston. In the past decade, he has worked on a broad range of challenging NLP topics and clinical NLP methods and systems developed in his lab have been highly recognized. He served as the Chair of AMIA NLP Working Group and currently also leads the NLP Working Group at OHDSI.